Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805
Ando, Munetoshi, Nagata, Keiko, Nihira, Kaito, Suzuki, Yui, Kanda, Yutaka, Adachi, Maiko, Kubota, Tsuguo, Kameyama, Naoya, Nakano, Mariko, Ando, Hiroshi, Yamano, Kazuya, Ishii, Toshihiko, Nakai, Ryuichiro, Nakamura, Kazuyasu
Published in Translational oncology (01.10.2017)
Published in Translational oncology (01.10.2017)
Get full text
Journal Article
Chicken ovalbumin promoter is demethylated upon expression in the regions specifically involved in estrogen-responsiveness
Morshed, M.(Nagoya Univ. (Japan)), Sano, S, Nishimiya, D, Ando, M, Nishijima, K, Iijima, S
Published in Bioscience, biotechnology, and biochemistry (01.06.2006)
Published in Bioscience, biotechnology, and biochemistry (01.06.2006)
Get full text
Journal Article
YY1 binds to regulatory element of chicken lysozyme and ovalbumin promoters
MORSHED, Mahboob, ANDO, Munetoshi, YAMAMOTO, Junko, HOTTA, Akitsu, KANEOKA, Hidenori, KOJIMA, Jun, NISHIJIMA, Ken-Ichi, KAMIHIRA, Masamichi, IIJIMA, Shinji
Published in Cytotechnology (Dordrecht) (01.11.2006)
Published in Cytotechnology (Dordrecht) (01.11.2006)
Get full text
Conference Proceeding
Journal Article
Abstract 2358: KHK2805, a novel ADCC- and CDC-enhanced anti-FOLR1 antibody with AccretaMab® technology, shows a potent anti-tumor activity in combination with pemetrexed
Ando, Munetoshi, Nagata, Keiko, Ishii, Toshihiko, Nakai, Ryuichiro, Takahashi, Takeshi
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Abstract 5311: KK2269, an epithelial cell adhesion molecule-targeted CD40 agonist, stimulates anti-tumor immunity resulting in sustained anti-tumor effect against mouse intrahepatic tumor without hepatotoxicity
Sumitomo, Yoshiki, Kawasaki, Kyoko, Tezuka, Yuta, Saito, Masato, Yao, Akari, Ando, Munetoshi
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 5310: KK2269, an epithelial cell adhesion molecule-targeted CD40 agonist, demonstrates antitumor effects in combination with standard therapies for NSCLC
Tezuka, Yuta, Kawasaki, Kyoko, Sumitomo, Yoshiki, Saito, Masato, Yao, Akari, Ando, Munetoshi
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs
Ando, Munetoshi, Tu, Wenjie, Nishijima, Ken-ichi, Iijima, Shinji
Published in Biochemical and biophysical research communications (09.05.2008)
Published in Biochemical and biophysical research communications (09.05.2008)
Get full text
Journal Article
Lectin-dependent localization of cell surface sialic acid-binding lectin Siglec-9
Ando, Munetoshi, Shoji, Toru, Tu, Wenjie, Higuchi, Hiroshi, Nishijima, Ken-ichi, Iijima, Shinji
Published in Cytotechnology (Dordrecht) (01.08.2015)
Published in Cytotechnology (Dordrecht) (01.08.2015)
Get full text
Journal Article
Abstract C124: A novel anti-FOLR1 antibody developed with AccretaMab® technology, KHK2805, exhibits potent anti-cancer activity against ovarian cancer samples with the FOLR1 expression
Nihira, Kaito, Ando, Munetoshi, Nagata, Keiko, Adachi, Maiko, Suzuki, Yui, Kanda, Yutaka, Oshima, Takeshi, Nan-ya, Ken-ichiro, Hiura, Masanori, Ishii, Toshihiko, Nakai, Ryuichiro, Takahashi, Takeshi
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article
Abstract C123: A novel anti-FOLR1 antibody developed with AccretaMab® technology, KHK2805, exhibits markedly high ADCC/CDC activity and a tolerable safety profile in preclinical models
Ando, Munetoshi, Nagata, Keiko, Ando, Hiroshi, Nakano, Mariko, Kameyama, Naoya, Kubota, Tsuguo, Adachi, Maiko, Suzuki, Yui, Nakamura, Kazuyasu, Ishii, Toshihiko, Nakai, Ryuichiro, Takahashi, Takeshi
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article
ANTI-FOLR1 ANTIBODY
KAMEYAMA NAOYA, NAKANO MARIKO, ANDO MUNETOSHI, ANDO HIROSHI, KUBOTA TSUGUO
Year of Publication 19.08.2015
Get full text
Year of Publication 19.08.2015
Patent
Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK28051
Ando, Munetoshi, Nagata, Keiko, Nihira, Kaito, Suzuki, Yui, Kanda, Yutaka, Adachi, Maiko, Kubota, Tsuguo, Kameyama, Naoya, Nakano, Mariko, Ando, Hiroshi, Yamano, Kazuya, Ishii, Toshihiko, Nakai, Ryuichiro, Nakamura, Kazuyasu
Published in Translational oncology (12.07.2017)
Published in Translational oncology (12.07.2017)
Get full text
Journal Article
ANTI-FOLR1 ANTIBODY
KAMEYAMA NAOYA, NAKANO MARIKO, ANDO MUNETOSHI, ANDO HIROSHI, KUBOTA TSUGUO
Year of Publication 12.06.2014
Get full text
Year of Publication 12.06.2014
Patent